These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3484964)
1. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Lecander I; Astedt B Br J Haematol; 1986 Feb; 62(2):221-8. PubMed ID: 3484964 [TBL] [Abstract][Full Text] [Related]
2. Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women. Nilsson IM; Felding P; Lecander I; Lennér C; Astedt B Br J Haematol; 1986 Feb; 62(2):215-20. PubMed ID: 3484963 [TBL] [Abstract][Full Text] [Related]
3. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators. Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018 [TBL] [Abstract][Full Text] [Related]
4. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Astedt B; Lecander I; Brodin T; Lundblad A; Löw K Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076 [TBL] [Abstract][Full Text] [Related]
5. Influence of delivery on plasminogen activator inhibitor activity. Koelbl H; Kirchheimer J; Tatra G J Perinat Med; 1989; 17(2):107-11. PubMed ID: 2681664 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
7. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor. Thorsen S; Philips M Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684 [TBL] [Abstract][Full Text] [Related]
8. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Philips M; Juul AG; Thorsen S Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors. Nakashima A; Kobayashi T; Terao T Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712 [TBL] [Abstract][Full Text] [Related]
10. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Kruithof EK; Tran-Thang C; Bachmann F Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. Häggroth L; Mattsson C; Felding P; Nilsson IM Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015 [TBL] [Abstract][Full Text] [Related]
13. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta. Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117 [TBL] [Abstract][Full Text] [Related]
14. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract. Radtke KP; Wenz KH; Heimburger N Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670 [TBL] [Abstract][Full Text] [Related]
15. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma. Sprengers ED Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification. Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936 [TBL] [Abstract][Full Text] [Related]
17. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. Colucci M; Paramo JA; Collen D J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245 [TBL] [Abstract][Full Text] [Related]
18. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]